Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
TYRA-300
i
Other names:
TYRA-300
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Tyra Biosci
Drug class:
FGFR3 inhibitor
Related drugs:
‹
erdafitinib (70)
B-701 (2)
HMPL-453 (1)
TT-00434 (1)
ABSK061 (0)
ASP5878 (0)
FPI-1966 (0)
HH185 (0)
LY2874455 (0)
LY3866288 (0)
R3Mab (0)
S-49076 (0)
SKI-G-801 (0)
erdafitinib (70)
B-701 (2)
HMPL-453 (1)
TT-00434 (1)
ABSK061 (0)
ASP5878 (0)
FPI-1966 (0)
HH185 (0)
LY2874455 (0)
LY3866288 (0)
R3Mab (0)
S-49076 (0)
SKI-G-801 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
FGFR3-TACC3 fusion + FGFR3 V555M
Urothelial Cancer
FGFR3-TACC3 fusion + FGFR3 V555M
Urothelial Cancer
TYRA-300
Sensitive: D – Preclinical
TYRA-300
Sensitive
:
D
TYRA-300
Sensitive: D – Preclinical
TYRA-300
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login